ArticleRheumatology advances in practice2021

Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis.

Sebastian-Jonas Saur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.